To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...
A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
Young people are finding fewer opportunities to develop skills, falling out of the workforce, and becoming angry at a system ...
Researchers used CRISPR to change the number of chromosomes in Arabidopsis by fusing chromosome arms, reducing the genome ...
CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand. The ...
The self-driving taxis have become ubiquitous in the city, but an uproar ensued when one ran over a beloved feline. Credit... Supported by By Heather Knight Reporting from San Francisco At Delirium, a ...
Putting people into sleep mode is a sci-fi concept that's a lot closer to becoming real than you might think. Erin Belback is part of an ongoing human trial backed by NASA that aims to replicate the ...
Will a human ever celebrate a 150th birthday? You bet, says Stephen Austad, a biology of ageing researcher at the University of Alabama at Birmingham. Austad is so sure that life expectancy is poised ...
JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in people with difficult-to-treat lipid disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback